Retroperitoneal Leiomyosarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2015-10-27
Clinical Trial Update: Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum [Phase 1, Phase 2]
Clinical trial update on a Phase 1/2 study of nilotinib in combination with Adriamycin for retroperitoneal liposarcoma and retroperitoneal l…